april, 2016

08apralldayalldayWORKSHOP: Preclinical translatability: holy grail or achievable goal?


Event Details

Speakers: Li Di (Pfizer), Chandra Prakash (Agios), Stan Spence (Novartis), Sanjeev Thohan (Novartis), Karuppiah Kannan (Takeda), Laszlo Urban (Novartis)
Organizers: Moderators: Sanjeev Thohan and Karuppiah Kannan
DateFriday, April 08, 2016
Time: 8:30-16:30
Registration fee (US$): (USD$)Regular: $175; For unemployed & students: $75; For major-sponsor rep (incl lunch): $0; All vendor reps except the rep paying for the vendor show: $125;
Location: Marriott Cambridge, 2 Cambridge Center, Cambridge, MA 02142
Major Sponsor: Absorption Systems
Vendor show vendors registered to date: Alliance Pharma; BASi; Corning Life Sciences; Pion Inc.; Protea Biosciences; QPS LLC; SOLVO Biotechnology US; WuXi/XBL
Registration: https://www.PBSS.org
Registration deadline:4/6/2016  (it will close sooner if the seating cap is reached)

With a faculty of distinguished speakers who are highly regarded experts and key opinion leaders, this symposia intends to discuss the pitfalls and benefits of preclinical findings as they are reflected in the clinical experience:

  • Basic and in-depth concepts of drug exposure, drug safety as they apply to discovery through development research activities.
  • In vitro tools for candidate selection in discovery and to predict/design in vivo preclinical studies.
  • Novel approaches to the identification, assessment and management of target organ toxicity.
  • A series of case studies on drug safety for liver, kidney, pancreas and heart and the biomarkers we can leverage.


All Day (Friday)


Marriott Cambridge

2 Cambridge Center, Cambridge, MA 02142